Introduction to workshop: adventitious viruses in biologics--detection and mitigation strategies

Area of Science:

• Biologics and Biopharmaceuticals
• Virology
• Regulatory Science

Background:

• Adventitious viruses pose a significant risk to the safety and efficacy of biological products.
• Effective detection and mitigation strategies are crucial for ensuring product quality and patient safety.
• Regulatory bodies and industry stakeholders must collaborate to address emerging viral threats.

Purpose of the Study:

• To convene experts to discuss current challenges and advancements in adventitious virus detection.
• To explore and share innovative strategies for mitigating viral contamination risks in biologics manufacturing.
• To foster dialogue between the Pharmaceutical Drug Association (PDA) and the Food and Drug Administration (FDA) on regulatory expectations and scientific approaches.

Main Methods:

• Presentations and discussions by leading scientists and regulatory experts.
• Review of current and emerging technologies for virus detection.
• Exploration of risk assessment and mitigation strategies throughout the biologics lifecycle.

Main Results:

• Identified gaps in current virus detection methodologies.
• Highlighted the need for harmonized approaches to virus safety testing.
• Emphasized the importance of a proactive, risk-based approach to viral contamination control.

Conclusions:

• Continued research and development are essential for improving adventitious virus detection sensitivity and specificity.
• Enhanced collaboration between industry and regulatory agencies is vital for implementing effective mitigation strategies.
• The workshop provided a critical platform for advancing the science and regulation of virus safety in biologics.